Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Residing with the same caregiver at least 5 days/week or every other week for the past 2 months and foreseeable future
Minimum developmental age of 2
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0, 3, 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will test whether the Family Check-Up can improve child well-being for families who receive it as part of their child's usual care within an autism service.
Who is the study for?
This trial is for children aged 6-17 with autism spectrum disorder (ASD) who show high levels of emotional and behavioral problems. They must be enrolled in the Ontario Autism Program, live with a caregiver consistently, and have a developmental age of at least 2 years. Parents need to speak English well enough for assessments but can't join if they're in another study or have done the Family Check-Up before.
What is being tested?
The trial is testing the 'Family Check-Up' program within an autism service setting. This program focuses on enhancing child well-being by empowering parents through identifying family strengths, goal-setting, positive parenting techniques, and connecting them to additional resources.
What are the potential side effects?
Since this intervention involves counseling and support services rather than medication, traditional side effects are not expected. However, participants may experience varying degrees of emotional discomfort when discussing personal issues during sessions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been living with my caregiver consistently for the past 2 months and will continue to do so.
Select...
My child is at least 2 years old in terms of development.
Select...
I am a child aged 6-17 with a confirmed autism diagnosis.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 0, 3, 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0, 3, 6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Aberrant Behavior Checklist (ABC) - irritability subscale
Change in Home Situation Questionnaire -ASD (HSQ-ASD)
Secondary study objectives
Change in Brief Coping Orientation to Problems Experienced (Brief COPE)
Change in Center for Epidemiological Studies Depression Scale - Revised (CESD-R)
Change in Generalized Anxiety Disorder-7 (GAD-7)
+5 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Family Check-UpExperimental Treatment1 Intervention
Families randomized to the Family Check-Up arm will be connected with a clinician who will provide the Family Check-Up. The Family Check-Up® (FCU) is an ecologically sensitive, evidence-based intervention that was developed to decrease childhood EBP by 1) assessing known ecological (child, family and contextual) risk and protective factors; 2) engaging parents in a tailored plan to enhance positive parenting and family management skills; and 3) connecting families to a tailored suite of child and family services and supports. Services may include an evidence-based suite of parenting sessions ("Everyday Parenting Curriculum \[EPC\]") created by FCU developers for direct tailoring to the FCU feedback session.
Group II: Treatment as UsualActive Control1 Intervention
Treatment as Usual participants will be connected to a Family Service Coordinator within the Autism Program, who can direct the family to appropriate services and resources. Services may include consultation on child behaviours, workshops on various topics, parenting programs, Applied Behaviour Analysis, support groups, and group recreational programs. Families in the treatment as usual arm will be offered the Family Check-Up upon completion of the study.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Family Check-Up
2021
N/A
~2480
Find a Location
Who is running the clinical trial?
McMaster UniversityLead Sponsor
917 Previous Clinical Trials
2,615,269 Total Patients Enrolled
7 Trials studying Autism Spectrum Disorder
533 Patients Enrolled for Autism Spectrum Disorder
Hamilton Health Sciences CorporationOTHER
377 Previous Clinical Trials
340,320 Total Patients Enrolled
1 Trials studying Autism Spectrum Disorder
52 Patients Enrolled for Autism Spectrum Disorder
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been living with my caregiver consistently for the past 2 months and will continue to do so.My child is at least 2 years old in terms of development.I am a child aged 6-17 with a confirmed autism diagnosis.
Research Study Groups:
This trial has the following groups:- Group 1: Family Check-Up
- Group 2: Treatment as Usual
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger